Top 15 Wellness Startup Investors in Taiwan (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
ITIC: Industrial Technology Investment Corporation
VC Fund
|
2 | United States, Taiwan, Japan | Series B, Seed, Series A | Health Care, Biotechnology, Software | $1M–$150M |
|
Sunplus
VC Fund
|
1 | Taiwan | Series A | Medical, Wellness, Therapeutics | |
|
Panacea Venture
VC Fund
|
1 | China, United States, Taiwan | Series A, Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $1.6M–$60M |
|
Hong TAI Electric Industrial
VC Fund
|
1 | Taiwan | Series A | Medical, Wellness, Therapeutics | |
|
Taiwania Capital Management Corporation
VC Fund
|
1 | United States, Taiwan, United Kingdom | Series A, Series B, Seed | Software, Artificial Intelligence, Biotechnology | $3M–$64M |
|
Mega Financial Holding
VC Fund
|
1 | ||||
|
Black Marble Capital Management
VC Fund
|
1 | Taiwan, Singapore, United States | Seed, Series C, Venture - Series Unknown | Biotechnology, Medical, Artificial Intelligence | $2.8M–$21M |
|
Vivo Capital
VC Fund
|
1 | United States, China, United Kingdom | Post-IPO Equity, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $28M–$180M |
|
Sino Biopharmaceutical
VC Fund
|
1 | China, United States, Israel | Series B, Series D, Series C | Biotechnology, Health Care, Medical | $27M–$736M |
|
TaiAn Technologies
VC Fund
|
1 | Taiwan, United States | Series A, Series B, Seed | Biotechnology, Medical, Therapeutics | $7.6M–$23M |
|
Guangzhou Yuexiu Industrial Investment Fund
VC Fund
|
1 | China, United States, Taiwan | Series B, Series C, Series A | Manufacturing, Biotechnology, Health Care | $1.6M–$600M |
|
Yan Jin
Angel
|
1 | Taiwan | Series A | Fitness, mHealth, Wellness | |
|
Maxpro Ventures
VC Fund
|
1 | Taiwan, United States | Venture - Series Unknown, Series A, Series B | Biotechnology, Medical, Health Care | $10M–$24M |
|
Suzhou Industrial Park Nankai Venture Capital
VC Fund
|
1 | Taiwan | Series A | Wellness, Health Care, Consumer Research | |
|
Zero2IPO Ventures
VC Fund
|
1 | China, Taiwan, India | Series A, Series B, Angel | E-Commerce, Internet, Education | $142k–$49M |
| Access all 21 investors in Taiwan Wellness startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Investor list
We are the venture capital arm of the renowned R&D consortium – the Industrial Technology Research Institute (ITRI). Since our creation in 1979, we have invested over US$400 million across virtually all stages, sectors, and timezones. Companies we have nurtured have gone on to define entire industries, and boast a combined market cap of wellover US$200 billion. Since its inception, ITIC has been instrumental in leading Taiwan's initial ventures into technology-based businesses, such as integrated circuits, automation, opto-electronic display, etc. ITIC is an original shareholder of some industry leaders such as UMC, Taiwan Mask Corp., Acer Display Technologies, Inc.(renamed as AU Optronics Corp.).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series B, Seed, Series A
- Geography: United States, Taiwan, Japan
Investor stats
- Total investments: 38
- Round size: Seed $1.9M–$12M; Series A $1M–$28M; Series B $7.6M–$150M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Syncell — Advance your research with microscopy-guided tools for high-res protein discovery & mapping. See how our workflow enhances precision and discovery depth.
- PopChill — PopChill generates an online marketplace for second-hand trade, enabling users to share their fashion styles and sell idle items.
- Rege Nephro — Rege Nephro is a biotech company that specialized in R&D, production and marketing of renal disease therapeutics.
Investment focus
- Industry: Medical, Wellness, Therapeutics
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: China, United States, Taiwan
Investor stats
- Total investments: 23
- Round size: Seed $13M–$50M; Series A $1.6M–$20M; Venture - Series Unknown $14M–$60M
- Lead/follow: 26% lead, 74% follow
- Last fund: May invest from a new fund soon — raised $257M in 2021
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Human Longevity — Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomicpowered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
- Eos BioInnovation — Discover Eos Bioinnovation's commitment to advancing sustainable biotechnology through innovative research and development. Explore our mission and services.
Hong TAI Electric Industrial manufactures electric cables, telecommunication cables, and copper wires.
Show more...Investment focus
- Industry: Medical, Wellness, Therapeutics
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
NEWS Nurturing Stalwarts of Future Industries Taiwan us [...]
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Taiwan, United Kingdom
Investor stats
- Total investments: 132
- Round size: Seed $3M–$11M; Series A $3M–$64M; Series B $11M–$55M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $194M in 2022
Portfolio highlights
- Luxonis — Build production-ready computer vision with OAK: AI depth cameras, stereo vision, and on-device inference for robotics, automation, and industrial applications.
- Syncell — Advance your research with microscopy-guided tools for high-res protein discovery & mapping. See how our workflow enhances precision and discovery depth.
- Shape Memory Medical — Smart polymer. Smart embolization. Smart choice. Reshaping your view of clinical success through the science of smart polymer.
Mega Financial Holding is a financial holding company engaged in the management of investment businesses. The company operates in four segments namely: Banking Business, Securities Business, Bill Banking, and Insurance Business. Through its subsidiaries, the Company accepts deposits, issues financial debentures, provides medium and long term loansto enterprises, as well as provides brokerage, dealer, and insurance services.Mega Financial Holding was founded in 2002 as CTB Financial Holding Company. The firm is based in Taipei, Taiwan.
Show more...Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
Black Marble Capital Management
Show more...Investment focus
- Industry: Biotechnology, Medical, Artificial Intelligence
- Stage:Seed, Series C, Venture - Series Unknown
- Geography: Taiwan, Singapore, United States
Investor stats
- Total investments: 15
- Round size: Seed $7M–$17M; Series C $14M–$21M; Venture - Series Unknown $2.8M–$21M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AIxMed — Beyond Human Insight | AIxMed, Inc.
- AnHorn Medicines — AnHorn Medicines is a drug discovery company that develops therapeutic medicines for cancer, neurodegeneration, and aging diseases.
- AnnJi Pharmaceutical — AnnJi Pharmaceutical is a clinical-stage drug development company that specializes in developing small molecules that address unmet medical needs in the areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy’s disease, and SBMA (Spinal and bulbar muscular atrophy). Thefocus of the company is on creating global collaborations and business partnerships in the late-stage product development and commercialization of pharmaceutical drugs.
The firm is a 25-year-old global investment firm focused on healthcare with approximately $5.8 billion in AUM, which we have invested in over 290 public and private companies worldwide. Headquartered in Palo Alto, California, with offices in Asia. Our team consists of 50 multi-disciplinary professionals, including, physicians, scientists,entrepreneurs, operating executives, and industry experts. The firm operates as a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Post-IPO Equity, Series B, Series C
- Geography: United States, China, United Kingdom
Investor stats
- Total investments: 260
- Round size: Series B $28M–$137M; Series C $30M–$142M; Post-IPO Equity $35M–$180M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fresh fund, raised $740M in 2025
Portfolio highlights
- Entera Bio — Entera Bio is developing novel oral drugs by utilizing its proprietary cutting edge delivery technology This technology protects large molecules and peptides in the GI tract. Oral drug delivery is the most straight forward and user friendly approach to medical treatment. Entera Bio has key personnel with the relevant know how, experience andnetworks working together to enable rapid development of its products. The company has an experienced management team with more than 50 years of combined drug development experience.
- Expedition Therapeutics — Redefining Care. Advancing COPD and Other Respiratory Therapies. Expedition Therapeutics is developing novel treatments for inflammatory and respiratory diseases with the potential to fundamentally transform patient care worldwide. ABOUT US At Expedition Therapeutics, we believe that disease-controlling treatments that address fundamental disease mechanisms should be the new standard for chronic obstructive pulmonary disease (COPD). Our
- BlossomHill Therapeutics — We are on a mission to exponentially improve the number of quality years for patients.
Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series D, Series C
- Geography: China, United States, Israel
Investor stats
- Total investments: 16
- Round size: Series B $91M–$110M; Series C $42M–$736M; Series D $27M–$400M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- TranscEngram — TranscEngram is an AI research and technology company focused on advancing artificial intelligence.
- AI² Robotics — AI² Robotics is an embodied intelligent robot company that offers research and development of general intelligent embodied terminals.
- Hongxin Biology — Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
TaiAn Technologies Corporation is a technology advisory company that specializes in commercializing intellectual properties in the life sciences. Our team comprised of numerous biomedical experts that work closely with investment professionals to support up-and-coming life science technologies. Most importantly, we are entrusted by our shareholdersto explore technology platforms in the life sciences arena, to build upon the novel technologies, and to transform them into viable business opportunities supporting existing or creating new entities. Our shareholders comprised of Development Fund of the Executive Yuan of Taiwan as well as numerous conglomerates that are recognized in Taiwan and internationally well known. Leveraging our shareholders/ partners' resources and our strong management team, our multiplex services create synergies with Taiwanese corporations and add significant value to your company.
Show more...Investment focus
- Industry: Biotechnology, Medical, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: Taiwan, United States
Investor stats
- Total investments: 9
- Round size: Series A $7.6M–$23M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Primo Biotechnology — Primo Biotechnology harnesses advanced molecular imagin
- AnBogen Therapeutics — Harness the Power of Science to Cure Cancer.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Guangzhou Yuexiu Industrial Investment Fund is a corporate investment arm of Yue Xiu Enterprises (Holdings) Limited.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Series B, Series C, Series A
- Geography: China, United States, Taiwan
Investor stats
- Total investments: 87
- Round size: Series A $1.6M–$600M; Series B $10M–$152M; Series C $25M–$182M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- GOWIN Semiconductor — Gowin Semiconductor Corp is a programmable solution provider!
- Huaying Zhongxing Aviation Technology — Huaying Zhongxing manufactures and sells intelligent UAVs. The company also distributes civil aviation materials and develops artificial intelligence theories and algorithm software.
Yan Jin has 15-year venture capital, investment banking, and corporate management experience covers more than 20 investment projects, involving consumer electronics, new materials, the Internet, and innovative services industries. Ms. Jin also serves as a leader of China’s Democratic National Construction Party, a political party separate from theCommunist Party of China. She is currently a legislative member of the Shenzhen Municipal Government. Ms. Jin is also a cofounder of Shenzhen Capital Group.
Show more...Investment focus
- Industry: Fitness, mHealth, Wellness
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- iFit — iFit (爱瘦身) is a website and mobile community that focuses on health and slimming services.iFit currently emphasizes on content, communities, and electronic commerce services. It plans on expanding its services into wearable equipment, application software, hardware services, and more. In March 2013, iFit gathered pictures and articles andpublished a book named Get Food not Fat, which was on the best-selling list once released. At the same time, IFit entered the group buying market.iFit was founded by Chen Yunru in June 2012. She started her business through a fan club by sharing her own experiences of losing weight. In less than a year her fan base reached more than 400,000. The official iFit website was set up in December 2012.
Maxpro Ventures is an investment firm focused on breakthrough biomedical technology companies. We identify and invest in such excellent companies worldwide with our private equity and venture capital expertise.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Series A, Series B
- Geography: Taiwan, United States
Investor stats
- Total investments: 13
- Round size: Series A $10M–$24M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Full Chain Materials International — Full Chain Materials is a Retail company focused on supplying and sourcing a broad range of chemicals and equipment to customers.
- Arthrosi Therapeutics — Arthrosi Therapeutics is a biotechnology company that focuses on drug discovery and development. The company was founded in 2017 and based in Laguna Hills, California.
- Elixiron Immunotherapeutics — Elixiron Immunotherapeutics is a company developing therapeutics for cancer, neurological diseases, and inflammatory disorders.
Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.
Show more...Investment focus
- Industry: Wellness, Health Care, Consumer Research
- Stage:Series A
- Geography: Taiwan
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.
Show more...Investment focus
- Industry: E-Commerce, Internet, Education
- Stage:Series A, Series B, Angel
- Geography: China, Taiwan, India
Investor stats
- Total investments: 94
- Round size: Angel $142k–$1.6M; Series A $1.4M–$29M; Series B $2.9M–$49M
- Lead/follow: 15% lead, 85% follow
- Last fund: May invest from a new fund soon — raised $40M in 2014
Portfolio highlights
- Makera — Makera builds the smartest desktop CNC machines for makers. Explore our Carvera series, versatile mill routers, and rich case templates for every project.
- Deep Cell — Deep Cell is a Chinese AI driven drug discovery and virtual cell modeling startup. The company integrates artificial intelligence with multi scale molecular physics to construct explainable virtual cell world models, aiming to revolutionize paradigm shifting drug designs and simulate cellular responses to complex diseases.
- Guangxiang Technology — Guangxiang Technology is dedicated to empowering industrial scenarios through embodied intelligence technology. The company has developed a general-purpose embodied intelligence development platform, centered around its core GOPS platform, to drive innovation and intelligent transformation in industrial applications.
Wellness Investor funding in Taiwan at a glance
Stats across 11 deals from 21 investors.
Access all 21 investors in Taiwan Wellness startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Wellness Investors in Taiwan investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 21 investors investing in Taiwan Wellness startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Sign up with Google
Sign up with LinkedIn
